Recent Advances in the Development of Antiviral Agents
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 January 2019) | Viewed by 86338
Special Issue Editor
Interests: virus evolution; macrophages; HIV pathogenesis; antivirals; HIV chemotherapy; microbicides; viral resistance; neuroAIDS; mechanisms of virus entry; chemokines and chemokine receptors; role of astrocytes and neurons in HIV infection
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Viral infections inflict many serious human diseases, especially in the most developing countries, with very high mortality rates. New drug-resistant strains are continually emerging due to the high viral mutation rate, which makes it necessary to develop novel and possibly more potent antiviral compounds. All researchers working in this field are cordially invited to contribute original research papers or reviews to this Special Issue of Molecules, which will report on the design, synthesis, and evaluation of novel antiviral drug or microbicide candidates against viral infections, the identification of novel biological targets or therapeutic approaches and rationale, or studies about antiviral resistance mechanisms and strategies to prevent and/or circumvent them.
Prof. Dr. Stefano Aquaro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Antivirials
- Drug design
- Drug synthesis
- Antiviral activity
- Viruses
- Antiviral resistence
- Virus evolution
- Antiviral therapy
- Virus entry
- Virus replication
- Viral enzimes
- Virus phatogenesis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.